1. Rubor, calor, dolor, tumor : infections de la peau et des tissus mous [Rubor, calor, dolor, tumor : skin and soft tissue infections]
- Author
-
Kampouri, E., Filippidis, P., Lhopitallier, L., Pham, T.T., Schuhler, C., Toutous Trellu, L., Mombelli, M., and Huttner, B.
- Subjects
Anti-Bacterial Agents/therapeutic use ,Fasciitis, Necrotizing/drug therapy ,Fasciitis, Necrotizing/microbiology ,Humans ,Immunoglobulins/therapeutic use ,Skin Diseases, Infectious/diagnosis ,Skin Diseases, Infectious/microbiology ,Skin Diseases, Infectious/surgery ,Skin Diseases, Infectious/therapy ,Soft Tissue Infections/diagnosis ,Soft Tissue Infections/microbiology ,Soft Tissue Infections/surgery ,Soft Tissue Infections/therapy ,Staphylococcal Infections/drug therapy ,Staphylococcal Infections/microbiology ,Staphylococcus aureus/drug effects - Abstract
Skin infections are a frequent cause of consultation, yet the diagnosis can be challenging for physicians. Microbiological documentation is rare, and empiric antibiotic regimens should cover the most commonly identified bacteria, i.e. streptococci Staphylococcus aureus. Other pathogens should be considered in case of immunosuppression or certain exposures. Necrotizing fasciitis (NF) is a severe but rare infection. Early surgical management in parallel with antibiotics is the cornerstone of treatment. Despite the high incidence of these infections, little progress has been made in their management and some areas of uncertainty exist, especially regarding the optimal duration of treatment, the prevention of recurrences and the use of polyclonal immunoglobulins for NF. This article reviews the main aspects of diagnosis and treatment of these infections.
- Published
- 2020